Teleflex Incorporated Stock

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-06-05 pm EDT 5-day change 1st Jan Change
215.4 USD +0.14% Intraday chart for Teleflex Incorporated +6.34% -13.63%
Sales 2024 * 3.09B Sales 2025 * 3.26B Capitalization 10.14B
Net income 2024 * 409M Net income 2025 * 543M EV / Sales 2024 * 3.63 x
Net Debt 2024 * 1.06B Net Debt 2025 * 507M EV / Sales 2025 * 3.27 x
P/E ratio 2024 *
27.8 x
P/E ratio 2025 *
19.1 x
Employees 14,500
Yield 2024 *
0.63%
Yield 2025 *
0.64%
Free-Float 97.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.14%
1 week+6.34%
Current month+3.00%
1 month+6.08%
3 months-3.55%
6 months-5.37%
Current year-13.63%
More quotes
1 week
206.01
Extreme 206.005
217.47
1 month
197.99
Extreme 197.99
220.27
Current year
197.99
Extreme 197.99
256.85
1 year
177.63
Extreme 177.633
262.97
3 years
177.63
Extreme 177.633
428.36
5 years
177.63
Extreme 177.633
449.38
10 years
101.95
Extreme 101.95
449.38
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 08-12-31
Director of Finance/CFO 62 11-07-31
Compliance Officer - 17-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-12-31
Director/Board Member 64 08-12-31
Director/Board Member 69 18-12-31
More insiders
Date Price Change Volume
24-06-05 215.4 +0.14% 385,400
24-06-04 215 +0.06% 441,707
24-06-03 214.9 +2.80% 693,545
24-05-31 209.1 +1.18% 1,163,126
24-05-30 206.6 +2.04% 887,539

Delayed Quote Nyse, June 05, 2024 at 04:00 pm EDT

More quotes
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
215.4 USD
Average target price
245.2 USD
Spread / Average Target
+13.88%
Consensus